1.Advances of endoluminal reconstruction of digestive tract in totally laparoscopic total gastrectomy
International Journal of Surgery 2020;47(4):280-284
With the improvement of laparoscopic instruments and laparoscopic surgical techniques, Abdominal minimally invasive surgery has developed rapidly, and laparoscopic gastric cancer surgery is also gradually becoming mature. For upper stomach cancer, gastric corpus cancer, linitis plastica, total laparoscopic total gastrectomy (TLTG) as a minimally invasive operation is widely used in clinical treatment of gastric cancer. Smaller surgical trauma, faster recovery, significantly increased perioperative quality of patients’ life. The technical points and difficulties of TLTG are how to complete digestive tract reconstruction under full laparoscopic monitoring. Totally laparoscopic esophagus jejunum anastomosis is a key problem for TLTG digestive tract reconstruction. Therefore, to explore the way of TLTG digestive tract reconstruction has become the focus of clinical researchers. The article will review the common surgical methods of TLTG digestive tract reconstruction in order to provide a better reference for the selection of clinical surgical methods.
2.Chaperonin containing T-complex protein 1 subunit epsilon (CCT5) serves as γδT cell-related autoantigen
Hui CHEN ; Da TENG ; Hongqin YOU ; Yunan GAO ; Jianmin ZHANG ; Wei HE
Basic & Clinical Medicine 2017;37(2):145-149
Objective To examine the relationship between CCT 5 ,γδ T cell and autoimmune diseases .Methods Recombinant CCT5 protein was cloned , expressed and purified in E.coli.Three peptides of CCT5 protein were used to prepare for anti-CCT5 monoclonal antibodies .Purified CCT5 protein was used to expand γδT cells from pe-ripheral blood mononuclear cells (PBMC).Plasma level of CCT5 in healthy donors, patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) were detected by ELISA assays .The correlation analysis between plasma CCT5 concentration and the percentage of different subtypes of γδT cells measured by flow cytometry was made . Results The CCT5 gene was amplified by PCR and the length of the target fragment was 1 750 bp.The expressed 65 ku CCT5 protein was purified and validated by SDS-PAGE.Two paired monoclonal anti-CCT5 antibodies were screened to detect CCT5 protein in plasma.Immobilized recombinant CCT5 protein was able to induce specific sig-nificant amplification of peripheral γδT cells.Correlation analysis of 10 healthy donors indicated significant corre-lation between the plasma CCT 5 concentration and the proportion of Vγ9 and Vδ2 γδ T cells.The plasma CCT5 concentration significantly decreased in autoimmune diseases patients , including RA and SLE .Conclusions These data suggest that CCT 5 could be a novel Vγ9δ2 γδT cell-related factor in autoimmune diseases , which deepen the understanding of Vγ9δ2 γδT cell function in autoimmune diseases .
3.Synchronous lung cancer in operation and brain infraction.
Meiling LI ; Hongqin HE ; Wenjin WANG ; Jianli WANG
Chinese Journal of Lung Cancer 2010;13(5):560-562
Adult
;
Cerebral Infarction
;
etiology
;
Humans
;
Intraoperative Complications
;
etiology
;
Lung Neoplasms
;
pathology
;
surgery
;
Male
4.Isolation and identification of three Marek's disease virus strains and sequence comparison of genes involved in pathogenesis
Yingnan LIU ; Fanfeng MENG ; Yang LI ; Peng SUN ; Huaibiao LUAN ; Hongqin SU ; He CUI ; Shuang CHANG ; Peng ZHAO ; Zhizhong CUI
Chinese Journal of Veterinary Science 2017;37(8):1479-1484,1500
To understand epidemiological characteristics of Marek's disease virus (MDV) prevalent in china currently,3 Marek's disease (MD) strains were isolated and identified from white feather meat chickens vaccined with MDV CVI988 or 814 through necropsy,histopathological observation,virus isolation and IFA detection,named SDAU1501,SDAU1502 and SDAU1503,respectively.vIL8,pp38,MEQ gene of the three strains of MDV were amplified using PCR,and compared with reference strains.The homology between SDAU1501 and SDAU1502 and virulent strains was above 97%,suggesting some features of virulent strains;while meq gene of SDAU1503 lost P amino acid at the 194 th site as that in CVI988,But the distinctive 177 nucleotide insertion mutations was not existed,predicting that it may be a attenuated vaccine strain.New variations of MDV continued and different types of variants emerged,therefore,prevalence and genetic monitoring of MD should be proceeded;meanwhile,more attentions should be given to MDV vaccine development.
5.Results of combined newborn hearing and deafness gene screening in Yuncheng area of Shanxi Province.
Hongqin HE ; Li SU ; Jia XU ; Yiwen WANG ; Yarong WANG ; Cui GUO ; Dandan LINGHU
Chinese Journal of Medical Genetics 2023;40(7):815-820
OBJECTIVE:
To analyze the clinical significance of combined newborn hearing and deafness gene screening in Yuncheng area of Shanxi Province.
METHODS:
Results of audiological examinations, including transient evoked otoacoustic emission and automatic discriminative auditory brainstem evoked potentials, for 6 723 newborns born in Yuncheng area from January 1, 2021 to December 31, 2021, were retrospectively analyzed. Those who failed one of the tests were considered to have failed the examination. A deafness-related gene testing kit was used to detect 15 hot spot variants of common deafness-associated genes in China including GJB2, SLC26A4, GJB3, and mtDNA12S rRNA. Neonates who had passed the audiological examinations and those who had not were compared using a chi-square test.
RESULTS:
Among the 6 723 neonates, 363 (5.40%) were found to carry variants. These have included 166 cases (2.47%) with GJB2 gene variants, 136 cases (2.03%) with SLC26A4 gene variants, 26 cases (0.39%) with mitochondrial 12S rRNA gene variants, and 33 cases (0.49%) with GJB3 gene variants. Among the 6 723 neonates, 267 had failed initial hearing screening, among which 244 had accepted a re-examination, for which 14 cases (5.73%) had failed again. This has yielded an approximate prevalence of hearing disorder of 0.21% (14/6 723). Among 230 newborns who had passed the re-examination, 10 (4.34%) were found to have carried a variant. By contrast, 4 out of the 14 neonates (28.57%) who had failed the re-examination had carried a variant, and there was a significant difference between the two groups (P < 0.05).
CONCLUSION
Genetic screening can provide an effective supplement to newborn hearing screening, and the combined screening can provide a best model for the prevention of hearing loss, which can enable early detection of deafness risks, targeted prevention measures, and genetic counseling to provide accurate prognosis for the newborns.
Infant, Newborn
;
Humans
;
Connexins/genetics*
;
Retrospective Studies
;
Deafness/genetics*
;
Connexin 26/genetics*
;
Neonatal Screening/methods*
;
Mutation
;
Genetic Testing/methods*
;
China/epidemiology*
;
Hearing
;
DNA Mutational Analysis
6.Digital breast tomosynthesis in diagnosis of dense breast lesions.
A'qiao XU ; Hongqin HE ; Qiujun SHI ; Zhiqing LI ; Shengjian ZHANG
Journal of Zhejiang University. Medical sciences 2019;48(2):186-192
OBJECTIVE:
To evaluate the value of digital breast tomosynthesis (DBT) in diagnosis of dense breast lesions.
METHODS:
Clinical and pathological data of 163 patients (58 benign lesions, 122 malignant lesions, and 180 lesions in total) with breast lesions undergoing surgical treatment in Shaoxing Central Hospital from January 2017 to December 2018 were retrospectively analyzed. The lesions were classified into non-homogeneous dense gland type and extremely dense gland type according to BI-RADS creterion. Breast MRI and DBT examinations were performed before the surgery. ROC curve was generated and the diagnostic efficacy of two examination methods for dense breast lesions was evaluated with pathological results as the gold standard. The detection rate, diagnostic accuracy of benign and malignant breast lesions were compared between two methods using chi-square test. The accuracy of lesion size preoperatively evaluated by MRI and DBT was analyzed by Pearson correlation.
RESULTS:
The detection rate and diagnostic accuracy for benign breast lesions by MRI were higher than those by DBT (91.4% vs. 75.9%, =5.098, <0.05 and 89.7% vs. 67.2%, =8.617, <0.01). But there were no significant differences in detection rate and accuracy for malignant lesions by MRI and DBT (98.4% vs. 95.1%, =2.068, >0.05 and 94.3% vs. 91.8%, =0.569, >0.05). The areas under the ROC curves of MRI, DBT based on BI-RADS classification were 0.910 and 0.832, respectively (=1.860, >0.05). The sensitivities of MRI, DBT to breast lesions were 93.3% and 86.7%, and the specificities were 68.3% and 79.1%. DBT and MRI measurements were positively correlated with pathological measurements (=0.887 and 0.949, all <0.01).
CONCLUSIONS
DBT can effectively diagnose benign and malignant breast lesions under dense gland background, and it has similar diagnostic efficacy with MRI for breast malignant lesions.
Breast Neoplasms
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Mammography
;
ROC Curve
;
Retrospective Studies